article thumbnail

How Has Patient Marketing Changed in the Digital Age?

Pharma Marketing Network

Navigating Compliance While personalization and interactivity are powerful, they must align with FDA regulations. Marketers must ensure that all promotional content includes accurate risk disclosures and avoids misleading claims. Yes, all promotional content must comply with FDA guidelines, including fair balance and risk disclosures.

article thumbnail

PPC Advertising Strategies for Pharma: Maximizing ROI

Pharma Marketing Network

So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Instead: Use disease-awareness campaigns focused on education rather than direct product promotion. The challenge? Google and Facebook prohibit direct targeting based on medical conditions.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Marketing in Pharma: Top Strategies for Executive Success

Pharma Marketing Network

From detailed product information to open dialogue about potential side effects, transparency fosters trust and credibility. Its why companies like Johnson & Johnson emphasize educational content alongside product promotions. Investing in tools like chatbots or telehealth platforms can further enhance the patient experience.

article thumbnail

Social Media Strategies for Pharma Marketing: Engaging HCPs & Patients

Pharma Marketing Network

Pharma brands have a responsibility to provide educational and empathetic content while avoiding direct product promotion. Compliance Challenges and How to Overcome Them Pharma marketing on social media comes with strict regulations , including: FDA and EMA guidelines restricting direct-to-consumer advertising.

Media 52
article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

Yeah, I even wanted to wear the shirt to this FDA meeting. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. Don Langsdorf (EHS): Shameless promotion, shameless product promotion.

Media 52